Lytix Biopharma: Annual Report for 2022 ...Middle East

PR Newswire - Economy
OSLO, Norway, March 30, 2023 /PRNewswire/ -- Lytix Biopharma AS ("Lytix") (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, announces that it has published its Annual Report for 2022, which was approved by the board of directors on March 29, 2023. "In the course of...

Read More Details
Finally We wish PressBee provided you with enough information of ( Lytix Biopharma: Annual Report for 2022 )

Apple Storegoogle play

Also on site :



Latest News